Please login to the form below

Not currently logged in
Email:
Password:

Gliadel

This page shows the latest Gliadel news and features for those working in and with pharma, biotech and healthcare.

Glioblastomas - a personalised future?

Glioblastomas - a personalised future?

Even agents approved within the last decade - a wafer formulation of carmustine (Gliadel) for implantation into the post-surgical tumour cavity and temozolomide (Temodal), an oral imidazotetrazine derivative of the alkylating

Latest news

  • Early 2013 sees drug filings, launches and approvals in Japan Early 2013 sees drug filings, launches and approvals in Japan

    Eisai and Nobelpharma have launched brain cancer drug Gliadel (carmustine), which becomes the only sustained-release formulation approved for intracranial implantation in Japan. ... Nobelpharma acquired manufacturing and marketing rights to Gliadel from

  • Back on track

    Gliadel wafers are implanted in the tumour cavity created in the brain after surgical removal and release carmustine slowly, directly to the tumour site. ... Gliadel has been shown to prolong the survival of patients significantly compared with those

  • New accounts: October

    Dermatology. Life. Link Pharmaceuticals. Gliadel implant. Oncology. Addjuice. Napp Pharmaceuticals. New product.

  • New accounts: November

    Pulsar Healthcare Communications. Link Pharmaceuticals. Gliadel implant. Oncology. Addjuice. Mayne Pharma.

  • New accounts: August

    Janssen-Cilag. Lyrinel XL. Urinary incontinence. PBC Communications. Link Pharmaceuticals. Gliadel implant.

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

DNA
Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...

Infographics